Lasa Supergenerics Ltd.
| BSE: 540702 | Sector: Health care |
| NSE: LASA | ISIN Code: INE670X01014 |
| BSE 00:00 | 19 May | 47.35 |
-2.10 (-4.25%) |
OPEN
47.50 |
HIGH
48.05 |
LOW
46.60 |
| NSE 00:00 | 19 May | 47.40 |
-2.15 (-4.34%) |
OPEN
48.00 |
HIGH
48.00 |
LOW
45.60 |
| OPEN | 47.50 |
| PREVIOUS CLOSE | 49.45 |
| VOLUME | 5107 |
| 52-Week high | 92.90 |
| 52-Week low | 38.15 |
| P/E | 102.93 |
| Mkt Cap.(Rs cr) | 193 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lasa Supergenerics Ltd. (LASA) - Latest News & Headlines
-
Lasa Supergenerics Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
03/05/2022 | bse |
Downlaod PDF -
Lasa Supergenerics Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
26/04/2022 | bse |
Downlaod PDF -
Lasa Supergenerics Ltd Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Discl
25/04/2022 | bse |
Downlaod PDF -
Lasa Supergenerics Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
25/04/2022 | bse |
Downlaod PDF -
Lasa Supergenerics Ltd Compliances - YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OFSEBI (LODR) REG
12/04/2022 | bse |
Downlaod PDF
-
Ruchi Soya acquires Patanjali Ayurved's food business for Rs 690 crore
1.32 am | 19 May 2022 | Business Standard
To pay 1% of turnover of products as annual royalty under transfer agreement
-
Ruchi Soya hits upper circuit on buyout of Patanjali's food retail business
3.58 pm | 18 May 2022 | Business Standard
The board also approved to change company's name from Ruchi Soya Industries to Patanjali Foods.
-
Gokaldas Exports surges 9%; hits all-time high on healthy business outlook
10.17 am | 18 May 2022 | Business Standard
A shift in consumer preferences post pandemic towards wovens, as people seek more formal clothes, may improve demand.
-
UltraTech, JSW lost Ambuja race due to CCI concerns: Holcim CEO
1.44 am | 18 May 2022 | Business Standard
The CEO said the smoothness of the execution of such a transaction was a major factor in taking the decision.
-
Street betting on revival of metals cycle amid buzz of over-correction
11.42 pm | 17 May 2022 | Business Standard
High input costs leading to margin pressure, lower-than-expected realisations are among downside risks
Quick Links for Lasa Supergenerics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
